DIABETIC RETINOPATHY AMONG TYPE 2 DIABETIC PATIENTS PRESENTING WITH MICROALBUMINURIA
Abstract
INTRODUCTION: Diabetes mellitus is becoming a major contributor of morbidity and mortality in Pakistan. Diabetic retinopathy is one of the leading causes of blindness in the world that increases the chances of loosing eye sight about 25 times higher as compared to normal individuals. There are many precipitating factors of retinopathy such as duration and type of diabetes, hyperglycemia and microalbuminuria.
OBJECTIVE: To determine the frequency of diabetic retinopathy among type 2 diabetic patients presenting with microalbuminuria.
METHODOLOGY: This was descriptive cross sectional study carried out in Endocrinology department Northwest General Hospital Peshawar Pakistan. The Duration of study was one year from 12 July 2015 to 20 August 2016. A total of 186 patients fulfilling the inclusion criteria were selected through consecutive sampling.
RESULTS: A total of 186 cases fulfilling the inclusion/exclusion criteria were enrolled in our study. Mean was 46.50 ± SD 6.61 and 58.06 % were male and 41.93% were female. Diabetic retinopathy was found that 53.76% while remaining 46.23% not having diabetic retinopathy.
CONCLUSION: We concluded that there is a significantly high association between diabetic retinopathy and microalbuminuria and these patients may be offered in time diagnosis and management of diabetic retinopathy considering microalbuminuria as a marker.
KEY WORDS: Frequency, Type 2 diabetes, diabetic retinopathy, microalbuminuria
References
Nisar S, Mateen F, Masud F. Frequency of retinopathy in type 2 diabetic patients with or without microalbuminuria. Pak J Med Health Sci 2010;4(4):479-83.
Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: A hospital-based study. Indian J Ophthalmol. 2009; 57(4):293-8.
Zhang W, Liu H, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal micro vascular complications. J Cardiovascular Dis Res 2011;2:96-103.
Mohan VKA, Nithyanandam S, Idiculla J. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. Indian J Ophthalmol 2011;59(3):207-10.
Antonetti DA, Klein R, Gardner TW. Diabetic Retinopathy. N Engl J Med 2012;366(13):1227-39.
Chen H, Zheng Z, Huang Y, Guo K, Lu J, Zhang L. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patient. PLoS One 2012;7(5):1-6.
Javadi MA, Katibeh M, Rafati N. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol. 2009;16:9-12
Taylor R, Williams R. Screening for Diabetic Retinopathy: An overview. Diabetic Medicine 1994;13:946-52.
Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology. 1993;100(6):862-7.
Manaviat MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmology 2004;4:9.
Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, Sharma T. Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetology & Metabolic Syndrome 2011;3:9.
Molitch ME, Steffes MW, Cleary PA, Nathan DM. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int 1993;43:668-74.
